US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist

0.6260
+0.0435+7.47%

Close Apr 18 16:00 ET

0.6400
+0.0140+2.24%

Post 19:57 ET

4.75MMarket Cap-23P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 12, 2022

(Q4)Dec 12, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

10.82%14.42M

-59.32%1.78M

-14.51%2.9M

173.43%5.15M

36.33%4.59M

68.90%13.01M

145.76%4.37M

60.57%3.4M

1.88M

3.37M

Selling and administrative expenses

47.44%11.21M

-50.66%1.52M

110.05%2.23M

237.56%3.93M

53.65%3.54M

36.29%7.61M

169.45%3.08M

-37.86%1.06M

--1.16M

--2.3M

-General and administrative expense

47.44%11.21M

-50.66%1.52M

110.05%2.23M

237.56%3.93M

53.65%3.54M

36.29%7.61M

169.45%3.08M

-37.86%1.06M

--1.16M

--2.3M

Research and development costs

-40.69%3.21M

-80.03%257.11K

-71.13%673.94K

69.67%1.22M

-1.03%1.06M

154.57%5.41M

103.07%1.29M

473.57%2.33M

--719.4K

--1.07M

Operating profit

-10.82%-14.42M

59.32%-1.78M

14.51%-2.9M

-173.43%-5.15M

-36.33%-4.59M

-68.90%-13.01M

-145.76%-4.37M

-60.57%-3.4M

-1.88M

-3.37M

Net non-operating interest income expense

100.11%457

99.80%-98

99.70%-210

99.78%-314

100.64%1.08K

47.95%-427.54K

75.71%-49.72K

69.24%-69.35K

-140.4K

-168.06K

Non-operating interest income

--457

---98

----

--1.08K

----

Non-operating interest expense

----

-99.70%210

----

-47.95%427.54K

-75.71%49.72K

-69.24%69.35K

----

--168.06K

Total other finance cost

----

-99.78%314

----

--140.4K

----

Other net income (expense)

-15,276.16%-93.33M

-6,422.63%-12.16M

-414,259.20%-81.18M

-237.46%-607K

-1,627.88%-186.4K

-149.59%-228.1K

19.6K

-212.1K

Gain on sale of security

----

-366.11%-607K

-1,627.88%-186.4K

-192.53%-228.1K

--19.6K

---212.1K

Special income (charges)

---93.33M

---12.16M

--0

---81.18M

----

--0

----

-Less:Impairment of capital assets

--11.9M

--0

--11.9M

----

--0

----

-Write off

--81.44M

--12.16M

--0

--69.28M

----

--0

----

Income before tax

-667.06%-107.75M

-202.78%-13.93M

21.39%-2.9M

-4,207.19%-86.33M

-22.48%-4.59M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

-2M

-3.75M

Income tax

-9.46M

-596.07K

-485

-7.81M

-1.05M

Net income

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

-2M

-3.75M

Net income continuous Operations

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

---2M

---3.75M

Minority interest income

Net income attributable to the parent company

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

-96.43%-3.69M

-2M

-3.75M

Preferred stock dividends

-20.64%7.95M

-99.67%32.37K

2,290.05%7.92M

10.02M

9.68M

331.2K

Other preferred stock dividends

Net income attributable to common stockholders

-341.53%-106.25M

-189.82%-13.34M

78.06%-2.93M

-3,600.80%-86.43M

5.46%-3.54M

-197.66%-24.06M

-133.72%-4.6M

-611.59%-13.38M

-2.34M

-3.75M

Basic earnings per share

-214.85%-108.97

81.44%-3.2918

93.89%-3.15

-4,740.00%-169.4

-152.01%-13.65

-147.43%-34.6104

-523.35%-17.7364

-1,797.86%-51.5535

-3.5

-5.4165

Diluted earnings per share

-214.85%-108.97

81.44%-3.2918

93.89%-3.15

-4,740.00%-169.4

-152.01%-13.65

-147.43%-34.6104

-523.35%-17.7364

-1,797.86%-51.5535

-3.5

-5.4165

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 12, 2022	(Q4)Dec 12, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	10.82%14.42M	-59.32%1.78M	-14.51%2.9M	173.43%5.15M	36.33%4.59M	68.90%13.01M	145.76%4.37M	60.57%3.4M	1.88M	3.37M
Selling and administrative expenses	47.44%11.21M	-50.66%1.52M	110.05%2.23M	237.56%3.93M	53.65%3.54M	36.29%7.61M	169.45%3.08M	-37.86%1.06M	--1.16M	--2.3M
-General and administrative expense	47.44%11.21M	-50.66%1.52M	110.05%2.23M	237.56%3.93M	53.65%3.54M	36.29%7.61M	169.45%3.08M	-37.86%1.06M	--1.16M	--2.3M
Research and development costs	-40.69%3.21M	-80.03%257.11K	-71.13%673.94K	69.67%1.22M	-1.03%1.06M	154.57%5.41M	103.07%1.29M	473.57%2.33M	--719.4K	--1.07M
Operating profit	-10.82%-14.42M	59.32%-1.78M	14.51%-2.9M	-173.43%-5.15M	-36.33%-4.59M	-68.90%-13.01M	-145.76%-4.37M	-60.57%-3.4M	-1.88M	-3.37M
Net non-operating interest income expense	100.11%457	99.80%-98	99.70%-210	99.78%-314	100.64%1.08K	47.95%-427.54K	75.71%-49.72K	69.24%-69.35K	-140.4K	-168.06K
Non-operating interest income	--457	---98	----	----	--1.08K	----	----	----	----	----
Non-operating interest expense	----	----	-99.70%210	----	----	-47.95%427.54K	-75.71%49.72K	-69.24%69.35K	----	--168.06K
Total other finance cost	----	----	----	-99.78%314	----	----	----	----	--140.4K	----
Other net income (expense)	-15,276.16%-93.33M	-6,422.63%-12.16M		-414,259.20%-81.18M		-237.46%-607K	-1,627.88%-186.4K	-149.59%-228.1K	19.6K	-212.1K
Gain on sale of security	----	----	----	----	----	-366.11%-607K	-1,627.88%-186.4K	-192.53%-228.1K	--19.6K	---212.1K
Special income (charges)	---93.33M	---12.16M	--0	---81.18M	----	--0	--0	--0	--0	----
-Less:Impairment of capital assets	--11.9M	--0	--0	--11.9M	----	--0	--0	--0	--0	----
-Write off	--81.44M	--12.16M	--0	--69.28M	----	--0	--0	--0	--0	----
Income before tax	-667.06%-107.75M	-202.78%-13.93M	21.39%-2.9M	-4,207.19%-86.33M	-22.48%-4.59M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	-2M	-3.75M
Income tax	-9.46M	-596.07K	-485	-7.81M	-1.05M	0	0	0	0	0
Net income	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	-2M	-3.75M
Net income continuous Operations	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	---2M	---3.75M
Minority interest income
Net income attributable to the parent company	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M	-96.43%-3.69M	-2M	-3.75M
Preferred stock dividends	-20.64%7.95M	0	-99.67%32.37K	2,290.05%7.92M		10.02M	0	9.68M	331.2K
Other preferred stock dividends
Net income attributable to common stockholders	-341.53%-106.25M	-189.82%-13.34M	78.06%-2.93M	-3,600.80%-86.43M	5.46%-3.54M	-197.66%-24.06M	-133.72%-4.6M	-611.59%-13.38M	-2.34M	-3.75M
Basic earnings per share	-214.85%-108.97	81.44%-3.2918	93.89%-3.15	-4,740.00%-169.4	-152.01%-13.65	-147.43%-34.6104	-523.35%-17.7364	-1,797.86%-51.5535	-3.5	-5.4165
Diluted earnings per share	-214.85%-108.97	81.44%-3.2918	93.89%-3.15	-4,740.00%-169.4	-152.01%-13.65	-147.43%-34.6104	-523.35%-17.7364	-1,797.86%-51.5535	-3.5	-5.4165
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall